The #1 Gold Play for Q2 🏆

Stocks continued their upward push on Monday with several indexes notching gains of more than 1%. The Nasdaq led, alongside the Russ2K.

Dow [+0.4%]
S&P 500 [+1.0%]
Nasdaq [+1.1%]
Russell 2K [+1.2%]

Futures are treading water in early trading. S&P 500 and Dow contracts are currently flat.

Disney’s earnings report is the most notable item on today’s schedule. The media stock’s financial results could provide insights into how economic uncertainty has impacted consumers’ spending habits on the company’s streaming services and movies.

The #1 Gold Play for Q2 🏆

From central banks to even Costco customers, it seems everyone is buying gold these days.

The yellow metal has been on an absolute tear this year, and it just set a new record high and the rally is showing no sign of slowing.

However, one overlooked gold opportunity could give you a much better shot at big returns than buying direct gold holdings.

Get the Details on this Unique Gold Stock HERE »

Zeta Global [ZETA] - Last Close: $13.00

Zeta Global is rallying after beating the consensus for revenues on its earnings report in Monday’s aftermarket.

The company reported a loss of $(0.23) per diluted share against the consensus of a $(0.25) loss.

Revenues came in at $194.9 million, which beat the $187.2 million analyst estimate, and Zeta hike its full-year sales guidance in response.

ZETA is up 18.3% but volume is thin at less than 100K.

My Take: ZETA’s has been on a tear lately and the market seems to be satisfied with this earnings report, so it could continue to charge along this upward tract for some time.

Clearmind Medicine [CMND] - Last Close: $1.17

Psychedelic therapeutic stock clear mind has acquired exclusive global rights to develop and commercialize novel compounds for PTSD.

The company acquired the rights via a licensing agreement with Yissum Research Development Company of the Hebrew University of Jerusalem

Clearmind is responsible for the ongoing development and potential commercialization in line with regulatory guidelines.

CMND is up 47.8% on over 8 million shares traded.

My Take: I don’t see a lot of substance behind CMND’s rally, so I advise caution here.

reAlpha Tech [AIRE] - Last Close: $0.8565

After yesterday’s close, reAlpha announced the closing of its previously announced acquisition of Naamche Inc. & its related subsidiaries.

The company says the deal will boost its talent pool with 43 new AI engineers, developers, UX designers, and creatives.

AIRE is up 45.9% on more than 6 million shares traded.

My Take: AIRE announced this deal months ago, so the sudden boost seems a bit out of place.

FibroGen [FGEN] - Last Close: $1.16

FibroGen is rallying after reporting stronger-than-expected revenues on its Q1 earnings report in Monday’s aftermarket.

The company missed the EPS estimate of a $(0.31) per share loss with a Q1 loss of $(0.33) per share.

Sales came in at $55.902 million against the consensus of $36.666 million by 52.4%, marking a YoY increase of 54.5%.

FGEN is up 19.8% on 5 million shares traded.

My Take: FGEN looks like it’s in the early phases of a rebound after seemingly bottoming out at $1 per share.

Gainers
Dogness [DOGZ] >> +17.9%
Esperion [ESPR] >> +8.0%
Faraday Futures [FFIE] >> +13.5%

Decliners
GreenPower Motor [GP] >> (35.7%)
AgriFORCE [AGRI] >> (30.9%)
Helius Medical [HSDT] >> (14.1%)

Walt Disney Company [DIS] ... AM
Duke Energy [DUK] ... AM
Transdigm [TDG] ... AM
Dba Sempra [SRE] ... AM
Datadog [DDOG] ... AM
Kenvue [KVUE] ... AM
Arista Networks [ANET] ... PM
McKesson [MCK] ... PM
Occidental Petroleum [OXY] ... PM
Coupang [CPNG] ... PM

Minneapolis Fed President Kashkari speaks ... 11:30a
Consumer credit [Apr] ... 3:00p